STK39 rs2962288: Understanding Genetic Links to Blood Pressure
The rs2962288 variant is a common genetic marker located within the STK39 gene. It has been identified in various genome-wide association studies as being linked to blood pressure regulation and susceptibility to essential hypertension.
What each genotype means
Baseline blood pressure association
This genotype is associated with the baseline risk profile for blood pressure regulation in the context of the STK39 gene. Research indicates that this variant is linked to essential hypertension, though the effect size is considered limited and may vary by ancestry. Please discuss your cardiovascular health and blood pressure monitoring with your clinician.
This genotype is common in many populations, though exact frequencies vary significantly by ancestral background.
Baseline blood pressure association
This genotype is associated with the baseline risk profile for blood pressure regulation in the context of the STK39 gene. Research indicates that this variant is linked to essential hypertension, though the effect size is considered limited and may vary by ancestry. Please discuss your cardiovascular health and blood pressure monitoring with your clinician.
This genotype is common in many populations, though exact frequencies vary significantly by ancestral background.
Baseline blood pressure association
This genotype is associated with the baseline risk profile for blood pressure regulation in the context of the STK39 gene. Research indicates that this variant is linked to essential hypertension, though the effect size is considered limited and may vary by ancestry. Please discuss your cardiovascular health and blood pressure monitoring with your clinician.
This genotype is common in many populations, though exact frequencies vary significantly by ancestral background.
What is the rs2962288 Variant?
The rs2962288 variant is a single nucleotide polymorphism (SNP) situated within the STK39 gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is located in a region of the genome that has been the subject of extensive investigation regarding cardiovascular health. Because it is a common variant, it is found frequently across many populations. Researchers use these markers to study how subtle differences in our genetic code might influence complex physiological traits, such as how the body maintains blood pressure. It is important to note that while this variant is statistically associated with blood pressure traits, it does not act as a standalone cause of hypertension, which is a complex condition influenced by a combination of many genetic factors, lifestyle choices, and environmental exposures.
The Role of the STK39 Gene
The STK39 gene provides instructions for producing a protein known as SPAK, or Ste20-related proline-alanine-rich kinase. This protein plays a critical role in the kidneys, specifically within the distal nephron. SPAK functions by interacting with WNK kinases and cation-chloride cotransporters, which are essential for regulating the balance of salt and water in the body. By modulating these transporters, the STK39-encoded protein helps control how much sodium is reabsorbed by the kidneys. Because sodium levels are a primary driver of blood volume and pressure, the activity of this gene is directly tied to the body's ability to maintain healthy blood pressure levels. Research into STK39 has even explored its potential as a target for therapeutic strategies, as inhibiting its activity might theoretically reduce sodium reabsorption and assist in blood pressure management.
Research and Evidence Strength
The association between STK39 variants and blood pressure was notably highlighted in early genome-wide association studies, such as those conducted in Amish populations, which identified the gene as a susceptibility locus for hypertension. Subsequent studies have sought to replicate these findings across diverse cohorts, including European and East Asian populations. While the evidence consistently points to a link between STK39 and blood pressure regulation, the strength of this association is generally considered limited or moderate in the context of clinical prediction. Many studies have observed that while the variant correlates with small, consistent changes in systolic and diastolic blood pressure, it is only one of many genetic contributors. Furthermore, some research has produced mixed results, with certain studies failing to find significant associations in specific cohorts, highlighting the complexity of genetic influence on blood pressure.
Interpreting Your Genetic Information
If you have information about your rs2962288 genotype, it is essential to view it as a single piece of a much larger puzzle. Genetic associations are statistical observations made across large groups of people and cannot predict an individual's health outcome. Having a specific genotype does not mean you will develop hypertension, nor does the absence of it guarantee protection. Because blood pressure is influenced by diet, physical activity, stress, and other genetic markers, this SNP should not be used for self-diagnosis or medical decision-making. If you are concerned about your blood pressure or cardiovascular health, the most effective approach is to consult with a healthcare professional. They can provide a comprehensive assessment based on your clinical history and current health status. Never make changes to medications or health routines based on genetic reports without first discussing them with your doctor or a qualified pharmacist.
How common is this variant?
The rs2962288 variant is a common genetic marker, with a minor allele frequency typically ranging between 0.15 and 0.25 in European and American populations.
Frequently asked questions
Does having the rs2962288 variant mean I have high blood pressure?
No. This variant is only one of many genetic factors associated with blood pressure regulation. It is not a diagnostic tool, and having a specific genotype does not determine whether you will develop hypertension.
Can I use this SNP to predict my risk of heart disease?
Genetic variants like rs2962288 provide only a very small amount of information regarding complex conditions like heart disease. Clinical risk is determined by a combination of genetics, lifestyle, and medical history, which a doctor must evaluate.
Should I change my diet based on my STK39 genotype?
You should not change your diet or medical regimen based on a single genetic variant. Always consult with a healthcare provider or a registered dietitian before making significant changes to your health habits.
Is STK39 a well-known gene for hypertension?
STK39 has been identified in several genome-wide association studies as a susceptibility gene for blood pressure traits. While it is recognized in the scientific community, it is just one of many genes involved in the complex regulation of blood pressure.
Sources & further reading
Educational information only, last refreshed 9/24/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2962288?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in STK39
This variant was investigated for its potential role in blood pressure response to thiazide diuretics, though clinical significance remains unproven.
Identified as a lead susceptibility locus associated with an increased risk of developing keratoconus in European cohorts.
